Oroxylin A attenuates psoriasiform skin inflammation by direct targeting p62 (sequestosome 1) via suppressing M1 macrophage polarization

Yuxiang Ma(China Pharmaceutical University), Lei Qiang(China Pharmaceutical University)
British Journal of Pharmacology
September 23, 2024
Cited by 11


Related Papers